TherapeuticsMD | TXMD - Cost Of Sales

Stock Price
2.29
Daily Change
0 0%
Monthly
1.33%
Yearly
126.73%
Q1 Forecast
2.17

TherapeuticsMD reported $-11.99M in Cost of Sales for its fiscal quarter ending in December of 2022.





Cost Of Sales Change Date
AbbVie USD 4.55B 757M Dec/2025
Cipla INR 29.1B 1.16B Dec/2025
Clal Biotechnology ILS 16.49M 2.64M Jun/2022
Compugen USD 3.54M 1.89M Dec/2025
CSL USD 3.87B 2.08B Dec/2025
Grifols EUR 1.51B 184.45M Dec/2025
Novo Nordisk DKK 1.95B 10.94B Jun/2025
Pfizer USD 6.29B 2.12B Dec/2025
TherapeuticsMD USD -11.99M 12.34M Dec/2022